Article

Development and Evaluation of Fast Dissolving Oral Films of Mefenamic Acid for the Management of Fever

Krishnameera Sajayan1★, Swathy KK1, Sarath Chandran C1, Jafna MC1, Rajesh Sreedharan Nair2, Sourav K1, Shijina Kappally3, Sreejith KR1, Jim Joseph4★ Corresponding author

  1. 1College of Pharmaceutical Sciences, Government Medical College Kannur, Pariyaram, Kerala, INDIA.
  2. 2School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor, MALAYSIA.
  3. 3College of Pharmacy, Sharjah University, Sharjah, UNITED ARAB EMIRATES.
  4. 4Sance Laboratories Pvt. Ltd., Pala, Kottayam, Kerala, INDIA.

CORRESPONDENCE

Krishnameera Sajayan

College of Pharmaceutical Sciences, Government Medical College Kannur, Pariyaram–670 503, Kerala, INDIA.

krishnameera1697@gmail.com

Received: 17-10-2022; Revised: 10-12-2022; Accepted: 12-01-2023.

Volume 57, Issue 1S · pp. s41–s51 · PUBLISHED 2023 · DOI: 10.5530/ijper.57.1s.6

View on IJPER original site ↗

ABSTRACT

The marketed formulations of Mefenamic Acid (MA) used for the treatment of fever in the paediatric population are reported to have several drawbacks. This study aimed to develop and evaluate the mefenamic acid–loaded oral dispersible films which may be a better alternative than the existing formulations. The solubility of mefenamic acid was enhanced by forming inclusion complexes with β cyclodextrin. The best ratio for the mefenamic acid-β cyclodextrin inclusion complex, 1:0.5 was selected based on the drug content and in vitro drug release. Fourier transform Infrared spectroscopy and scanning electron microscopy analysis was performed on the complex. The oral dispersible films were developed by solvent casting method and evaluated for parameters such as average weight, thickness, pH, folding endurance, percentage moisture uptake and loss, drug content, in vitro disintegration time and drug release. The statistical analysis of the data suggested that oral dispersible films with 4% w/v of crospovidone (coded P3) as the best. Drug content (95.46±0.93%), disintegration time (28.6±2.0 s), cumulative percentage drug release (97.41±0.68% in 180 s), and all other investigated parameters of P3 were well within the acceptable limit. The in vitro dissolution profile of P3 showed no significant difference from the marketed mefenamic acid suspension and has a good stability profile at in-house testing conditions. The data obtained from this investigation revealed that mefenamic acid oral dispersible films could act as an excellent alternative to existing marketed paediatric formulations.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Sajayan, K., KK, S., C, S. C., MC, J., Nair, R. S., K, S., Kappally, S., KR, S., & Joseph, J. (2023). Development and Evaluation of Fast Dissolving Oral Films of Mefenamic Acid for the Management of Fever. Indian Journal of Pharmaceutical Education and Research, 57(1S), s41–s51. https://doi.org/10.5530/ijper.57.1s.6